Experimental and Clinical Pharmacology

Medicine & Life Sciences

1. Pharmacokinetics 100%
2. Epilepsy 55%
3. Anticonvulsants 52%
4. Pharmaceutical Preparations 49%
5. Pharmacogenetics 49%
6. Phenytoin 47%
7. Seizures 46%
8. Genes 43%
9. Single Nucleotide Polymorphism 39%
10. Therapeutics 37%
11. Carbamazepine 27%
12. Genotype 27%
13. Population 27%
14. Transplants 26%
15. Transplant Recipients 24%
16. Muscarinic M1 Receptors 24%
17. HIV 23%
18. Fenofibrate 23%
19. Elderly 23%
20. Kidney 23%
21. Phenotype 22%
22. Schizophrenia 21%
23. xanomeline 20%
24. Vancomycin 20%
25. Child 20%
26. Serum 19%
27. Mutation 19%
28. Brain 19%
29. Status Epilepticus 19%
30. Psychotic Disorders 19%
31. Alzheimer Disease 18%
32. Genome-Wide Association Study 18%
33. Neoplasms 18%
34. Safety 18%
35. Levetiracetam 18%
36. Monophenol Monooxygenase 18%
37. Tacrolimus 17%
38. Nursing Homes 17%
39. Genome 17%
40. Felbamate 17%
41. Alleles 17%
42. Cytochrome P-450 Enzyme System 17%
43. Placebos 17%
44. Cell Line 17%
45. Lipids 17%
46. Topiramate 17%
47. In Vitro Techniques 16%
48. Antipsychotic Agents 16%
49. Biomarkers 16%
50. Muscarinic M2 Receptors 16%
51. Cell Transplantation 15%
52. Diazepam 15%
53. Area Under Curve 15%
54. Oculocutaneous albinism type 1 15%
55. Pharmacogenomic Testing 15%
56. Mycophenolic Acid 14%
57. Pediatrics 14%
58. Breast Neoplasms 14%
59. Enzymes 14%
60. Lamotrigine 14%
61. Drug Therapy 13%
62. Cognition 13%
63. Doxorubicin 13%
64. Nitric Oxide Synthase Type I 13%
65. Clinical Trials 13%
66. MicroRNAs 13%
67. Gene Expression 12%
68. Ligands 12%
69. Cricetulus 12%
70. Zonisamide 12%
71. Fluoroquinolones 12%
72. Quality of Life 12%
73. Mindfulness 12%
74. Staphylococcus aureus 12%
75. Cytochrome P-450 CYP2D6 11%
76. Proteins 11%
77. Anti-Bacterial Agents 11%
78. Oculocutaneous Albinism 11%
79. Pharmacology 11%
80. fosphenytoin 11%
81. Cytochrome P-450 CYP3A 11%
82. Genetic Variation 11%
83. Nicotine 11%
84. Nitric Oxide 11%
85. HDL Lipoproteins 11%
86. Serotonin Uptake Inhibitors 10%
87. Pharmacists 10%
88. Pseudomonas aeruginosa 10%
89. Drug Interactions 10%
90. gemcitabine 10%
91. Health 10%
92. Carbachol 10%
93. Ovary 10%
94. Human Genome 10%
95. Drug Resistant Epilepsy 10%
96. HapMap Project 10%
97. Mortality 10%